# Varda Space Industries Space-manufacturing and re-entry startup founded in January 2021 by [[Delian Asparouhov]] (President) and Will Bruey (CEO, a former [[SpaceX]] engineer). Varda builds small autonomous orbital capsules that manufacture pharmaceuticals and advanced materials in microgravity and return the finished product to Earth — a business that doubles as a dual-use platform for hypersonic re-entry testing (see [[Defense Tech Ecosystem]]). ## Business Model Varda's pitch is that certain crystalline drug formulations and materials form better in microgravity than they can on Earth. Each mission flies a manufacturing payload to orbit aboard a rideshare bus, processes material in space, then returns it inside a heat-shielded re-entry capsule. The same re-entry vehicle is a hypersonics testbed, which is what makes Varda attractive to the Pentagon as well as to pharma. ## Missions - **W-1 (Winnebago-1):** First mission, launched 2023. Its return was delayed for months when the FAA initially declined re-entry permission; the agency granted a license on February 14, 2024, and the capsule landed at the Utah Test and Training Range on **February 21, 2024** — one of the first commercial space-manufactured products returned to Earth. - By mid-2025 Varda reported it had completed **three** launch-and-return missions, with **W-4** in orbit and a fifth planned — a rapid cadence relative to typical space hardware. ## Funding - Backed from the start by [[Founders Fund]], [[Khosla Ventures]], [[Lux Capital]], [[General Catalyst]], Caffeinated Capital, and others. - **July 2025:** Closed a **$187M Series C** at a reported ~$500M valuation (led by Natural Capital and Shrug Capital, with [[Peter Thiel]] participating), bringing total funding to roughly $329M. - Reporting in early 2026 indicated a subsequent Series D lifting the valuation past $1.5B, marking Varda's move into unicorn territory. ## Defense / Dual-Use In January 2023 Varda secured a roughly **$60M contract with the [[U.S. Air Force]]** for its re-entry vehicle technology, underscoring that the capsule — not just the drugs inside it — is the strategically valuable asset. This dual-use posture places Varda squarely inside the defense-tech buildout promoted by [[Delian Asparouhov]]'s other venture, the [[Hill and Valley Forum]], and the [[All-In Podcast]] circle. ## Significance Varda is the operating company that turns [[Delian Asparouhov]] from a pure financier into a founder with a concrete stake in the space/defense agenda he advocates politically. It is a textbook [[Founders Fund]] play: a hard-tech moonshot with a national-security angle, a Thiel-world investor base, and a partner-as-operator at the helm — the same pattern seen with [[Trae Stephens]] and [[Anduril]]. ## See Also - [[Delian Asparouhov]] - [[Founders Fund]] - [[Hill and Valley Forum]] - [[Defense Tech Ecosystem]] - [[U.S. Air Force]] - [[SpaceX]]